Spaero Bio

Spaero Bio is a San Francisco-based laboratory automation software company founded in 2020. The company's mission is to eliminate the bottleneck of manual liquid-handling pipework in life science research by giving scientists a no-code, intelligent interface to define, run, and fine-tune automated experiments using liquid handlers already present in their labs.

At the core of Spaero's platform is a combination of machine learning, computer vision, and robotic integration that works with virtually any commercial liquid handler. Scientists can specify experimental protocols in plain terms, and the Spaero system translates those instructions into precise robotic commands, adapting in real time as protocols or sample inputs change. This approach removes the need for specialised programming skills and dramatically reduces the time required to move from experimental design to execution.

Spaero's technology addresses a critical pain point in life sciences R&D: liquid handling is one of the most repetitive and error-prone tasks in a biology lab, yet it underpins nearly every high-throughput workflow in drug discovery, genomics, synthetic biology, and diagnostics. By layering AI-driven optimisation over existing hardware, Spaero allows teams to scale automation without replacing their existing equipment investments.

The company serves biotechnology, pharmaceutical, and academic research organisations. It was admitted as a member of Greentown Labs, a prominent climate and life sciences incubator. Spaero has raised a total of $6 million in funding from investors including Acequia Capital, Compound, Cantos, Whoa Ventures, Spacecadet Ventures, and AlleyCorp. The company has approximately eight employees and participates in industry forums such as SLAS (Society for Laboratory Automation and Screening).